The “Sweet Spot” Revisited: Optimal Recall Rates for Cancer Detection With 2D and 3D Digital Screening Mammography in the Metro Chicago Breast Cancer Registry

2021 ◽  
Vol 216 (4) ◽  
pp. 894-902
Author(s):  
Garth H. Rauscher ◽  
Anne Marie Murphy ◽  
Qiong Qiu ◽  
Therese A. Dolecek ◽  
Katherine Tossas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Registry ◽  
Cancer Detection ◽  
Screening Mammography ◽  
Sweet Spot ◽  
2D And 3D ◽  
Breast Cancer Registry

scholarly journals Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry

2016 ◽  
Vol 156 (3) ◽  
pp. 485-494 ◽  
Author(s):  
Takayuki Iwamoto ◽  
Hiraku Kumamaru ◽  
Hiroaki Miyata ◽  
Ai Tomotaki ◽  
Naoki Niikura ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Registry ◽  
Breast Cancers ◽  
Breast Cancer Registry

scholarly journals Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry

2017 ◽  
Vol 77 (08) ◽  
pp. 870-878 ◽  
Author(s):  
Markus Wallwiener ◽  
Felix Heindl ◽  
Sara Brucker ◽  
Florin-Andrei Taran ◽  
Andreas Hartkopf ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Advanced Breast Cancer ◽  
Cancer Registry ◽  
Data Entry ◽  
Metastatic Breast ◽  
Advanced Breast ◽  
Patient Reported ◽  
Trial Staff ◽  
Breast Cancer Registry

Abstract Purpose Patient-reported outcomes (PROs) have been incorporated into clinical trials for many symptoms and medical conditions. A transition from paper-based capture of PROs to electronic PROs (ePROs) has recently started. This study reports on the feasibility of ePRO assessment in a prospective registry including molecular data for patients with advanced breast cancer. Methods As part of the PRAEGNANT network, patients were invited by clinical trial staff, physicians, and nurses to complete three standardized Internet-based questionnaires (EQ 5D 5 L, CES-D and IPAQ). Feasibility was assessed by the staff members who assigned the user accounts by the patients. The completeness of the questionnaires was also assessed. Results Fifteen of 17 patients who were asked agreed to participate to complete the PRO questionnaires (EQ-5D-5L and CES-D). However, the IPAQ (physical activity) questionnaire was only validly completed by 9 patients. Feasibility was ranked better by the physicians and dedicated clinical trial staff than by the nursing staff. Conclusions Incorporating ePRO questionnaires into an advanced breast cancer registry is feasible, and no major hurdles were reported. Involving stakeholders from the start, the application is tailored to the capacities and abilities of both patients and clinical staff. The patientsʼ compliance was better with some questionnaires, but others may present difficulties.

scholarly journals Tumoral Lymphocytic Infiltration and Expression of the Chemokine CXCL10 in Breast Cancers from the Ontario Familial Breast Cancer Registry

2012 ◽  
Vol 19 (2) ◽  
pp. 336-346 ◽  
Author(s):  
Anna Marie Mulligan ◽  
Irene Raitman ◽  
Linda Feeley ◽  
Dushanthi Pinnaduwage ◽  
Linh T. Nguyen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Registry ◽  
Familial Breast Cancer ◽  
Lymphocytic Infiltration ◽  
Breast Cancers ◽  
Breast Cancer Registry

Clinical Observations from a Breast Cancer Registry in Asian Women

2007 ◽  
Vol 31 (7) ◽  
pp. 1387-1392 ◽  
Author(s):  
Siew-Eng Lim ◽  
Michael Back ◽  
Esther Quek ◽  
Philip Iau ◽  
Thomas Putti ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Registry ◽  
Asian Women ◽  
Clinical Observations ◽  
Breast Cancer Registry

Breast Cancer Registry in Palermo and Its Province

2006 ◽  
Vol 963 (1) ◽  
pp. 85-90 ◽  
Author(s):  
A. TRAINA ◽  
R. CUSIMANO ◽  
M. LIQUORI ◽  
V. FERRIGNO ◽  
A. GUTTADAURO ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Registry ◽  
Breast Cancer Registry
Sign in / Sign up

Export Citation Format

Share Document